Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 8658
Gene Symbol: TNKS
TNKS
0.040 Biomarker disease BEFREE APC truncating mutations in Middle Eastern Population: Tankyrase inhibitor is an effective strategy to sensitize APC mutant CRC To 5-FU chemotherapy. 31704613 2020
Entrez Id: 3909
Gene Symbol: LAMA3
LAMA3
0.010 GeneticVariation disease BEFREE The PAC-5 signature (LAMA3, E2F7, IFI44, SLC12A2, and LRIG1) that had significant prognostic value in the overall dataset was established, independently of the pathological stage. 31703415 2019
Entrez Id: 972
Gene Symbol: CD74
CD74
0.010 Biomarker disease BEFREE Moreover, MIF-injected mice had lesser left atrium fractional shortening, greater atrial fibrosis, and atrial ectopic beats than control (nonspecific immunoglobulin treated) or MIF combined with anti-CD74 neutralized antibody-treated mice. 31669150 2020
Entrez Id: 23082
Gene Symbol: PPRC1
PPRC1
0.010 GeneticVariation disease BEFREE Seventy-five cases were identified in the pulmonary sinus cusps (PSCs, 32 in left sinus cusp (PLC), 15 in right (PRC), 28 in anterior (PAC)) and 31 cases were in the main stem of pulmonary artery (MSPA, 18 above PLC (LMSPA), 3 above PRC (RMSPA), 10 above PAC (AMSPA)). 31640555 2019
Entrez Id: 6331
Gene Symbol: SCN5A
SCN5A
0.120 GeneticVariation disease BEFREE We identified a novel SCN5A variant (A1656D) in a LQTS patient with a distinct response to mexiletine resulting in suppression of non-sustained ventricular tachycardia and manifestation of premature atrial contraction. 31506521 2019
Entrez Id: 7852
Gene Symbol: CXCR4
CXCR4
0.020 AlteredExpression disease BEFREE Only SST1 and CXCR4 expression was detected in PAC tumours, with SST1 present in 42.3% and CXCR4 in 7.7% of cases. 31451931 2019
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
0.030 Biomarker disease BEFREE Infection with genotoxin-producing Salmonella enterica synergises with loss of the tumour suppressor APC in promoting genomic instability via the PI3K pathway in colonic epithelial cells. 31414579 2019
Entrez Id: 5294
Gene Symbol: PIK3CG
PIK3CG
0.030 Biomarker disease BEFREE Infection with genotoxin-producing Salmonella enterica synergises with loss of the tumour suppressor APC in promoting genomic instability via the PI3K pathway in colonic epithelial cells. 31414579 2019
Entrez Id: 5293
Gene Symbol: PIK3CD
PIK3CD
0.030 Biomarker disease BEFREE Infection with genotoxin-producing Salmonella enterica synergises with loss of the tumour suppressor APC in promoting genomic instability via the PI3K pathway in colonic epithelial cells. 31414579 2019
Entrez Id: 5291
Gene Symbol: PIK3CB
PIK3CB
0.030 Biomarker disease BEFREE Infection with genotoxin-producing Salmonella enterica synergises with loss of the tumour suppressor APC in promoting genomic instability via the PI3K pathway in colonic epithelial cells. 31414579 2019
Entrez Id: 406988
Gene Symbol: MIR205
MIR205
0.010 Biomarker disease BEFREE APC was found to be a validated target of miR-205 and down-regulated in pancreatic cancer. 31391772 2019
Entrez Id: 8658
Gene Symbol: TNKS
TNKS
0.040 GeneticVariation disease BEFREE Distinct Colorectal Cancer-Associated APC Mutations Dictate Response to Tankyrase Inhibition. 31337618 2019
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.010 Biomarker disease BEFREE As a result, 3K3A-APC treatment lowers C9ORF72 dipeptide repeat protein (DPR) levels, restores nuclear TDP-43 localization, and rescues the survival of both C9ORF72 and sporadic ALS iMNs. 31310593 2019
Entrez Id: 324
Gene Symbol: APC
APC
0.100 Biomarker disease BEFREE To understand and dissect the mechanisms driving human NK cell proliferation, we exploited the methodology used in cell therapy to numerically expand NK cells in the presence of K562-derived artificial APC (aAPCs) and cytokines. 31201235 2019
Entrez Id: 3600
Gene Symbol: IL15
IL15
0.020 Biomarker disease BEFREE Finally, synergy between IL-15 and IL-21 was observed only upon CD137 engagement and the presence of aAPCs. 31201235 2019
Entrez Id: 50616
Gene Symbol: IL22
IL22
0.010 Biomarker disease BEFREE Finally, synergy between IL-15 and IL-21 was observed only upon CD137 engagement and the presence of aAPCs. 31201235 2019
Entrez Id: 59067
Gene Symbol: IL21
IL21
0.010 Biomarker disease BEFREE Finally, synergy between IL-15 and IL-21 was observed only upon CD137 engagement and the presence of aAPCs. 31201235 2019
Entrez Id: 3604
Gene Symbol: TNFRSF9
TNFRSF9
0.010 Biomarker disease BEFREE Finally, synergy between IL-15 and IL-21 was observed only upon CD137 engagement and the presence of aAPCs. 31201235 2019
Entrez Id: 8744
Gene Symbol: TNFSF9
TNFSF9
0.010 AlteredExpression disease BEFREE Similarly, the low NK cell proliferation in the presence of the parental K562 cell line and cytokines was increased by adding agonistic anti-CD137 Abs to levels similar to CD137L-expressing K562-derived aAPCs. 31201235 2019
Entrez Id: 7514
Gene Symbol: XPO1
XPO1
0.010 AlteredExpression disease BEFREE <i>XPO1</i> expression refines the prognostication in PAC and higher expression exists in secondary versus primary tumors, which supports the development of <i>XPO1</i> inhibitors in this so-lethal disease. 31052304 2019
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.090 Biomarker disease BEFREE We calculated diagnostic performances for the cytology alone, cytology+IHC and cytology+KRAS to show the best method to diagnose PAC. 30929285 2019
Entrez Id: 4582
Gene Symbol: MUC1
MUC1
0.010 Biomarker disease BEFREE The addition of IHC either with CEA or MUC1 improved the diagnostic performance of the cytology alone to diagnose PAC. 30929285 2019
Entrez Id: 1048
Gene Symbol: CEACAM5
CEACAM5
0.010 Biomarker disease BEFREE The addition of IHC either with CEA or MUC1 improved the diagnostic performance of the cytology alone to diagnose PAC. 30929285 2019
Entrez Id: 5624
Gene Symbol: PROC
PROC
0.010 GeneticVariation disease BEFREE During 2 h MCAo both WT murine APC and its mutant, 5A-APC, significantly decreased neuronal death 30 min after reperfusion. 30880117 2019
Entrez Id: 442891
Gene Symbol: MIR135B
MIR135B
0.030 Biomarker disease BEFREE Our results indicated that SMAD5-AS1 inhibits DLBCL proliferation by sponging miR-135b-5p to up-regulate APC expression and inactivate classic Wnt/β-catenin pathway, suggesting that SMAD5-AS1 may act as a potential biomarker and therapeutic target for DLBCL. 30874550 2019